Interactions of beta-blockers with model lipid membranes: molecular view of the interaction of acebutolol, oxprenolol, and propranolol with phosphatidylcholine vesicles by time-dependent fluorescence shift and molecular dynamics simulations
Jazyk angličtina Země Nizozemsko Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
24681296
DOI
10.1016/j.ejpb.2014.03.013
PII: S0939-6411(14)00102-7
Knihovny.cz E-zdroje
- Klíčová slova
- Drug-membrane interactions, Dtmac, Generalized polarization, Laurdan, Lipid hydration, MD, NME, Prodan, Solvent relaxation,
- MeSH
- acebutolol metabolismus MeSH
- beta blokátory metabolismus MeSH
- fluorescence MeSH
- fluorescenční barviva metabolismus MeSH
- fosfatidylcholiny metabolismus MeSH
- glycerol metabolismus MeSH
- lipidové dvojvrstvy metabolismus MeSH
- liposomy metabolismus MeSH
- membránové lipidy metabolismus MeSH
- oxprenolol metabolismus MeSH
- propranolol metabolismus MeSH
- simulace molekulární dynamiky MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- 1-palmitoyl-2-oleoylphosphatidylcholine MeSH Prohlížeč
- acebutolol MeSH
- beta blokátory MeSH
- fluorescenční barviva MeSH
- fosfatidylcholiny MeSH
- glycerol MeSH
- lipidové dvojvrstvy MeSH
- liposomy MeSH
- membránové lipidy MeSH
- oxprenolol MeSH
- propranolol MeSH
Since pharmacokinetic and pharmacodynamic activities of drugs are often related to their interactions with biomembranes, it is of high interest to establish an approach for the characterization of these interactions at the molecular level. For the present study, beta-blockers (oxprenolol, propranolol, and acebutolol) were selected due to their well described nonspecific membrane effects (NME). Their interactions with model lipid membranes composed of palmitoyloleoylphosphatidylcholine (POPC) were studied using Time-Dependent Fluorescence Shift (TDFS) and Generalized Polarization (GP) as well as molecular dynamics (MD) simulations. Liposomal vesicles were labeled with fluorescent membrane polarity probes (Laurdan, Prodan, and Dtmac). Increasing beta-blocker concentrations (0-10 mM for acebutolol and oxprenolol, and 0-1.5 mM for propranolol) significantly rigidifies the lipid bilayer at the glycerol and headgroup level, which was detected in the steady-state and in the time-resolved fluorescence data. The effects of propranolol were considerably stronger than those of the two other beta-blockers. The addition of fluorescent probes precisely located at different levels within the lipid bilayer revealed the insertion of the beta-blockers into the POPC bilayer at the glycerol backbone level, which was further confirmed by MD simulations in the case of propranolol.
Citace poskytuje Crossref.org